Detection of acalculous gallbladder disease using Tc99m EHIDA imaging and cholecystokinin
| Autor: | J. H. Williams, G. W. Middleton |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
medicine.medical_specialty
medicine.diagnostic_test business.industry Cholecystography medicine.medical_treatment Gallbladder digestive oral and skin physiology Gallbladder disease General Medicine medicine.disease Gastroenterology Endoscopy medicine.anatomical_structure Cholescintigraphy Internal medicine medicine Radiology Nuclear Medicine and imaging Cholecystectomy Prospective cohort study business Cholecystokinin |
| Zdroj: | European Radiology. 4:462-463 |
| ISSN: | 1432-1084 0938-7994 |
| DOI: | 10.1007/bf00212822 |
| Popis: | The use of Tc99m ethyl hepatic iminodiacetic acid (EHIDA) imaging with cholecystokinin (CCK) in a prospective study of 115 patients with right upper quadrant biliary-type pain is described. All patients had normal US, oral cholecystography and/or endoscopy investigations. A 2-min infusion of CCK was administered at peak gallbladder uptake of EHIDA. A gallbladder ejection fraction (CBEF) was used to quantify the gallbladder response to CCK. A total of 79 of 115 patients (69%) had an abnormal GBEF (≤ 35%). Of 43 patients who underwent cholecystectomy 42 (97%) had abnormal surgical/histological findings and/or complete long-term relief of symptoms. It was concluded that Tc99m EHIDA imaging, with a 2-min infusion of CCK and a measured GBEF ≤ 35%, is highly predictive of acalculous gallbladder disease and a favourable outcome following cholecystectomy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink